Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients

BACKGROUND: Cytochrome P450 2C19 (CYP2C19) genotypes and metabolic phenotypes (extensive metabolizer (EM), intermediate metabolizer (IM), and poor metabolizer (PM)) are related to the metabolism of therapeutic drugs for cardiovascular and cerebrovascular diseases. This study aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuliang, Yang, Yuxian, Feng, Miaoling, Ling, Weihan, Wei, Tongguo, Cao, Yumin, Zhong, Rui, Wu, Heming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438470/
https://www.ncbi.nlm.nih.gov/pubmed/37601806
http://dx.doi.org/10.2147/IJGM.S420108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438470/
https://www.ncbi.nlm.nih.gov/pubmed/37601806
http://dx.doi.org/10.2147/IJGM.S420108

Ejemplares similares